vs

Side-by-side financial comparison of CG Oncology, Inc. (CGON) and Robin Energy Ltd. (RBNE). Click either name above to swap in a different company.

Robin Energy Ltd. is the larger business by last-quarter revenue ($3.6M vs $2.3M, roughly 1.5× CG Oncology, Inc.).

CG Oncology, Inc. is a clinical-stage biotechnology company focused on developing innovative targeted immunotherapies for urological cancers including non-muscle invasive bladder cancer. It primarily operates in the U.S. market, advancing pipeline candidates to address unmet medical needs for patients with limited treatment options.

NextEra Energy, Inc. is an American energy company that is the world's largest electric utility holding company by market capitalization, with a valuation of over $170 billion as of Oct 2024. NextEra Energy had revenues of $24.8 billion and 16,700 employees throughout the US and Canada in 2024. It has a current generating capacity of 73 gigawatts. Its subsidiaries include Florida Power & Light (FPL), NextEra Energy Resources (NEER), XPLR Energy Partners, and NextEra Energy Services.

CGON vs RBNE — Head-to-Head

Bigger by revenue
RBNE
RBNE
1.5× larger
RBNE
$3.6M
$2.3M
CGON

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
CGON
CGON
RBNE
RBNE
Revenue
$2.3M
$3.6M
Net Profit
$-41.3M
Gross Margin
Operating Margin
-2097.3%
12.1%
Net Margin
-1779.0%
Revenue YoY
409.2%
Net Profit YoY
-29.9%
EPS (diluted)
$-0.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CGON
CGON
RBNE
RBNE
Q4 25
$2.3M
Q3 25
$1.7M
Q2 25
$0
$3.6M
Q4 24
$456.0K
Q1 24
$529.0K
Net Profit
CGON
CGON
RBNE
RBNE
Q4 25
$-41.3M
Q3 25
$-43.8M
Q2 25
$-41.4M
Q4 24
$-31.8M
Q1 24
$-16.9M
Operating Margin
CGON
CGON
RBNE
RBNE
Q4 25
-2097.3%
Q3 25
-3069.0%
Q2 25
12.1%
Q4 24
-8344.1%
Q1 24
-4247.4%
Net Margin
CGON
CGON
RBNE
RBNE
Q4 25
-1779.0%
Q3 25
-2629.5%
Q2 25
Q4 24
-6973.7%
Q1 24
-3200.8%
EPS (diluted)
CGON
CGON
RBNE
RBNE
Q4 25
$-0.52
Q3 25
$-0.57
Q2 25
$-0.54
Q4 24
$-0.47
Q1 24
$-0.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CGON
CGON
RBNE
RBNE
Cash + ST InvestmentsLiquidity on hand
$742.2M
$39.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$752.6M
$20.5M
Total Assets
$791.6M
$48.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CGON
CGON
RBNE
RBNE
Q4 25
$742.2M
Q3 25
$680.3M
Q2 25
$661.1M
$39.4M
Q4 24
$742.0M
Q1 24
$566.5M
Stockholders' Equity
CGON
CGON
RBNE
RBNE
Q4 25
$752.6M
Q3 25
$687.6M
Q2 25
$670.4M
$20.5M
Q4 24
$733.4M
Q1 24
$568.9M
Total Assets
CGON
CGON
RBNE
RBNE
Q4 25
$791.6M
Q3 25
$729.9M
Q2 25
$701.4M
$48.6M
Q4 24
$754.8M
Q1 24
$579.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CGON
CGON
RBNE
RBNE
Operating Cash FlowLast quarter
$-36.2M
Free Cash FlowOCF − Capex
$-36.2M
FCF MarginFCF / Revenue
-1560.0%
Capex IntensityCapex / Revenue
0.3%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-124.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CGON
CGON
RBNE
RBNE
Q4 25
$-36.2M
Q3 25
$-38.9M
Q2 25
$-28.0M
Q4 24
$-20.7M
Q1 24
$-26.0M
Free Cash Flow
CGON
CGON
RBNE
RBNE
Q4 25
$-36.2M
Q3 25
$-39.0M
Q2 25
$-28.0M
Q4 24
$-20.9M
Q1 24
$-26.0M
FCF Margin
CGON
CGON
RBNE
RBNE
Q4 25
-1560.0%
Q3 25
-2340.4%
Q2 25
Q4 24
-4577.0%
Q1 24
-4919.5%
Capex Intensity
CGON
CGON
RBNE
RBNE
Q4 25
0.3%
Q3 25
5.8%
Q2 25
0.0%
Q4 24
45.8%
Q1 24
2.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons